Telemedical Algorithm-Supported Care for Hypertension

The SOT-ART-HT study is a single-center, randomized, open-label trial aimed at comparing two strategies for managing arterial hypertension. Patients in the control group will receive standard care, which includes regular visits to a hypertension clinic, while those in the intervention group will receive remote care through a specialized tele-informatic system designed to assist the physician. The trial will involve 200 participants, aged 18-80, with confirmed arterial hypertension and uncontrolled office blood pressure at the screening visit. Both primary and secondary outcomes will be evaluated, with the study expected to be completed after 2026. However, early termination could occur if required by regulatory bodies, an Ethics Committee, or the Scientific Research Committee.

Inclusion criteria

• Voluntarily signing an informed consent to participate in the study.
• Age between 18 and 80 years.
• Diagnosis of hypertension according to the Polish Society of Hypertension criteria from 2019, either already treated or newly diagnosed.
• Blood pressure exceeding 140/90 mmHg in office measurements (during the screening visit).

Exclusion criteria

• Suspicion or diagnosis of secondary hypertension.
• Pregnant women, breastfeeding women, or those planning pregnancy during the study period.